Compare Oscar Health Inc (OSCR) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance

Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.

The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.

SHY trades at $81.96, showing minimal daily movement with a slight decline of 0.04%. The technical outlook is mixed with a bullish overall signal but bearish moving averages, while key support and resistance cluster around $82. Recent corporate actions include consistent dividend payments of $0.24, with the latest scheduled for July 2026. Financial ratios are not disclosed in the provided data, limiting fundamental visibility.

The outlook for SHY is clouded by incomplete financial data, though steady dividends provide income appeal. Key risks include interest rate sensitivity amid Federal Reserve uncertainty, as bond market volatility could impact performance. Investors should seek updated SEC filings for fundamental clarity before considering positions.